Honest Comparison · June 2026
REMEVi vs. Yucca Health
Both are LegitScript-certified and licensed in all 50 states. Where REMEVi stands apart: native bilingual English/Spanish care and pricing published upfront. Here's exactly what we found — no spin.
Side-by-side
REMEVi vs. Yucca Health feature by feature
Based on publicly available data, pricing pages, and patient reviews — June 2026.
| Feature | REMEVi | Yucca Health |
|---|---|---|
| Semaglutide — lowest advertised | ✅ $199/mo (52-wk) · $279/mo monthly — all-inclusive | ~$146/mo (6-mo new-patient promo) · ~$206/mo ongoing |
| Tirzepatide — lowest advertised | ✅ $269/mo (52-wk) · $379/mo monthly | ~$258/mo (6-mo new-patient promo) · ~$325/mo ongoing |
| Pricing shown upfront? | ✅ Yes — all plan prices published | ⚠️ Shared only after intake |
| Separate membership fee | ✅ None — care, meds & shipping bundled | ✅ None (bundled) |
| Spanish-language support | ✅ Fully bilingual (built-in) | ❌ No Spanish support found (Jun 2026) |
| Bilingual care coordinator | ✅ Assigned to every patient | ❌ Not offered |
| LegitScript certified | ✅ Certified | ✅ Certified |
| All-inclusive price | ✅ Yes — one all-inclusive price | ✅ Yes |
Pricing and features subject to change. Always verify current pricing on each provider's website.
The bilingual difference
Built bilingual — not retrofitted
We did not find Spanish-language support on Yucca Health's site as of June 2026. REMEVi was built bilingual from the ground up. Every intake form, provider note, care coordinator message, and patient touchpoint is available in fluent English and Spanish.
GLP-1 programs
How the GLP-1 programs compare
Both REMEVi and Yucca Health offer compounded semaglutide and tirzepatide for weight loss, both bundle medication and shipping with no separate membership fee, both are LegitScript certified, and both are licensed in all 50 states. The meaningful differences are in pricing transparency, language support, and the structure of the headline price.
On pricing: Yucca Health advertises low new-patient promotional pricing — approximately $146/month for semaglutide and approximately $258/month for tirzepatide — which requires a 6-month plan; its ongoing rates are higher, around $206/month for semaglutide and around $325/month for tirzepatide. REMEVi is $199/month for semaglutide and $269/month for tirzepatide on the 52-week plan, all-inclusive. Neither is simply "cheaper" — the right comparison depends on the plan length and term you choose, so verify current pricing directly on each provider's site.
On price transparency: Yucca Health's own FAQ states that pricing is shared after intake once eligibility is confirmed. REMEVi publishes every plan price openly before you sign up, so you can see exactly what each plan and medication costs ahead of time.
On support: REMEVi assigns every patient a dedicated bilingual care coordinator with a 2-hour response target. For patients managing side effects, dosage questions, or medication concerns, response time and language support matter significantly.
On clinical oversight: Both platforms use licensed US providers for prescribing, and prescription approval typically occurs within 24 hours. Yucca Health also offers "+" preparations (Semaglutide+ / Tirzepatide+) that add a B12 component.
On language: This is where the platforms diverge. We did not find Spanish-language support on Yucca Health's site as of June 2026. REMEVi's entire platform — intake forms, clinical summaries, medication instructions, care coordinator communications — is available natively in English and Spanish. For the 62 million Spanish-speaking Americans, this is a fundamental difference in the quality of care they receive.
FAQ
Common questions
Yes, especially if pricing transparency or Spanish-language care matter to you. Yucca Health is a legitimate, LegitScript-certified provider licensed in all 50 states, and REMEVi is too. Where REMEVi stands apart is native bilingual English/Spanish care with a dedicated bilingual care coordinator and a 2-hour response target, plus published pricing on every plan before you sign up. Compare both on the factors that matter most to you.
Yucca Health advertises low new-patient pricing of approximately $146/month for semaglutide and approximately $258/month for tirzepatide on a 6-month plan; ongoing rates are higher (around $206/month for semaglutide and around $325/month for tirzepatide). REMEVi is $199/month for semaglutide and $269/month for tirzepatide on the 52-week plan, all-inclusive, with pricing published upfront. Always verify current pricing on each provider's site, as telehealth pricing changes frequently.
Yucca Health's own FAQ states that pricing is shared after intake once eligibility is confirmed. REMEVi publishes all plan prices openly on its pricing page before you sign up, so you can see exactly what you will pay for each plan and medication ahead of time.
We did not find Spanish-language support on Yucca Health's site as of June 2026. REMEVi is the only telehealth platform we know of built natively bilingual — every intake form, care coordinator, and patient message is available in fluent English and Spanish from day one.
Yucca Health is a legitimate provider: it is LegitScript certified and licensed in all 50 states, the same trust credentials REMEVi holds. On top of those, REMEVi adds native bilingual English/Spanish care and a dedicated bilingual care coordinator with a 2-hour response target. Both are credible options; the right choice depends on whether bilingual care and upfront pricing are priorities for you.
Yes. Switching is straightforward — complete REMEVi's 5-minute intake form, a clinician reviews your case within 24 hours, and your medication ships within days. You do not need to formally cancel Yucca Health before starting with REMEVi; simply time your transition to avoid overlapping charges. Compounded medications are non-FDA-approved preparations prepared by state-licensed compounding pharmacies and are not generic versions of, nor the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
Compare REMEVi with other GLP-1 providers
See how REMEVi stacks up on price, bilingual support, and transparency.
Ready to get started with REMEVi?
Clinical review in 24 hours. No insurance needed. From $199/mo on 52-week plan, all-inclusive.
Start free consultation